Korean J Gastroenterol.  2015 Jun;65(6):354-360. 10.4166/kjg.2015.65.6.354.

Enteral Nutritional Support in Gastrointestinal and Liver Diseases

• Kim ER

• KMID: 2373237
• DOI: http://doi.org/10.4166/kjg.2015.65.6.354

Abstract

Nutritional support is important because malnutrition is a major contributor to increased morbidity and mortality, decreased quality of life, increased length of hospital stay, and higher healthcare costs. Patients with gastrointestinal disease are at an increased risk of nutritional deterioration due to therapeutic dietary restriction, fasting for the diagnostic tests, loss of appetite due to anorexia or altered nutritional requirement caused by the disease itself. Therefore, it is important that gastroenterologists are aware of the nutritional status of patients and plan a treatment strategy considering patient's nutritional status. Enteral nutrition is preferred to parenteral nutrition as it is more physiologic, has fewer complications, help to prevent mucosal atrophy and maintain gut barrier function, which decrease intestinal bacterial translocation. Hence, enteral nutrition has been considered to be the most effective route for nutritional support. In this article, we will review enteral nutrition (oral nutritional supplements, enteral tube feeding) as a treatment for the patients with gastrointestinal, liver and pancreatic disease at risk of malnutrition.

Keyword

Enteral nutrition; Inflammatory bowel diseases; Liver diseases; Nutritional support; Pancreatic diseases

MeSH Terms

*Enteral Nutrition
Gastrointestinal Diseases/*pathology/therapy
Humans
Liver Diseases/*pathology/therapy
Malnutrition/*prevention & control
Nutrition Therapy
Nutritional Support
Quality of Life

Reference

References

1. Kyle UG, Genton L, Pichard C. Hospital length of stay and nutritional status. Curr Opin Clin Nutr Metab Care. 2005; 8:397–402.

2. Lim SL, Ong KC, Chan YH, Loke WC, Ferguson M, Daniels L. Malnutrition and its impact on cost of hospitalization, length of stay, readmission and 3-year mortality. Clin Nutr. 2012; 31:345–350.

3. Jensen GL, Compher C, Sullivan DH, Mullin GE. Recognizing malnutrition in adults: definitions and characteristics, screening, assessment, and team approach. JPEN J Parenter Enteral Nutr. 2013; 37:802–807.

4. McWhirter JP, Pennington CR. Incidence and recognition of malnutrition in hospital. BMJ. 1994; 308:945–948.

5. Chang DK. Hospital malnutrition. Intest Res. 2013; 11:238–242.

6. Baik HW. Nutritional therapy in gastrointestinal disease. Korean J Gastroenterol. 2004; 43:331–340.

7. Baik HW. Nutritional therapy in hospital. J Korean Med Assoc. 2014; 57:491–495.

8. Jeon WK. Complement and integrative approach in gut health and immunologic disease. Hanyang Med Rev. 2010; 30:109–114.

9. Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am J Clin Nutr. 2003; 78:675–683.

10. Gebbers JO, Laissue JA. Immunologic structures and functions of the gut. Schweiz Arch Tierheilkd. 1989; 131:221–238.

11. Gopalan S, Khanna S. Enteral nutrition delivery technique. Curr Opin Clin Nutr Metab Care. 2003; 6:313–317.

12. Lochs H, Allison SP, Meier R, et al. Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics. Clin Nutr. 2006; 25:180–186.

13. Anker SD, John M, Pedersen PU, et al. ESPEN guidelines on enteral nutrition: cardiology and pulmonology. Clin Nutr. 2006; 25:311–318.

14. Cano N, Fiaccadori E, Tesinsky P, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006; 25:295–310.

15. Kreymann KG, Berger MM, Deutz NE, et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr. 2006; 25:210–223.

16. Plauth M, Cabré E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006; 25:285–294.

17. Lee KM. Nutrition in inflammatory bowel disease. Korean J Gastroenterol. 2008; 52:1–8.

18. Kim KO. Management of anemia in patients with inflammatory bowel disease. Korean J Gastroenterol. 2015; 65:145–150.

19. Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J Gastroenterol. 2009; 15:2570–2578.

20. Yoon SY, Jung SA. Nutritional support in patients with inflammatory bowel diseases. Intest Res. 2013; 11:243–249.

21. Lochs H, Dejong C, Hammarqvist F, et al. ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr. 2006; 25:260–274.

22. Schütz T, Herbst B, Koller M. Methodology for the development of the ESPEN guidelines on enteral nutrition. Clin Nutr. 2006; 25:203–209.

23. Forbes A. Review article: Crohn's disease–the role of nutritional therapy. Aliment Pharmacol Ther. 2002; 16(Suppl 4):48–52.

24. Wright RA, Adler EC. Peripheral parenteral nutrition is no better than enteral nutrition in acute exacerbation of Crohn's disease: a prospective trial. J Clin Gastroenterol. 1990; 12:396–399.

25. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007; (1):CD000542.

26. Shanbhogue RL, Bistrian BR, Jenkins RL, Jones C, Benotti P, Blackburn GL. Resting energy expenditure in patients with end-stage liver disease and in normal population. JPEN J Parenter Enteral Nutr. 1987; 11:305–308.

27. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition. 2003; 19:515–521.

28. Campillo B, Richardet JP, Bories PN. Enteral nutrition in severely malnourished and anorectic cirrhotic patients in clinical practice. Gastroenterol Clin Biol. 2005; 29:645–651.

29. Plank LD, Gane EJ, Peng S, et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology. 2008; 48:557–566.

30. Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Müller MJ. ESPEN Consensus Group. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr. 1997; 16:43–55.

31. Yoshida T, Muto Y, Moriwaki H, Yamato M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn. 1989; 24:692–698.

32. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr. 2006; 136(1 Suppl):295S–298S.

33. Marchesini G, Bianchi G, Merli M, et al. Italian BCAA Study Group. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003; 124:1792–1801.

34. de Lédinghen V, Beau P, Mannant PR, et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci. 1997; 42:536–541.

35. Grant JP. Nutritional support in acute and chronic pancreatitis. Surg Clin North Am. 2011; 91:805–820. viii.

36. Meier R, Ockenga J, Pertkiewicz M, et al. ESPEN guidelines on enteral nutrition: pancreas. Clin Nutr. 2006; 25:275–284.

37. Dickerson RN, Vehe KL, Mullen JL, Feurer ID. Resting energy expenditure in patients with pancreatitis. Crit Care Med. 1991; 19:484–490.

38. Hill GL. Jonathan E. Rhoads lecture. Body composition research: implications for the practice of clinical nutrition. JPEN J Parenter Enteral Nutr. 1992; 16:197–218.

39. Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut. 1998; 42:431–435.

40. Al-Omran M, Albalawi ZH, Tashkandi MF, Al-Ansary LA. Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev. 2010; (1):CD002837.

41. Eckerwall GE, Tingstedt BB, Bergenzaun PE, Andersson RG. Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery–a randomized clinical study. Clin Nutr. 2007; 26:758–763.

42. Eatock FC, Brombacher GD, Steven A, Imrie CW, McKay CJ, Carter R. Nasogastric feeding in severe acute pancreatitis may be practical and safe. Int J Pancreatol. 2000; 28:23–29.

43. Jiang K, Chen XZ, Xia Q, Tang WF, Wang L. Early nasogastric enteral nutrition for severe acute pancreatitis: a systematic review. World J Gastroenterol. 2007; 13:5253–5260.

44. Chang YS, Fu HQ, Xiao YM, Liu JC. Nasogastric or nasojejunal feeding in predicted severe acute pancreatitis: a metaanalysis. Crit Care. 2013; 17:R118.

45. Tiengou LE, Gloro R, Pouzoulet J, et al. Semi-elemental formula or polymeric formula: is there a better choice for enteral nutrition in acute pancreatitis? Randomized comparative study. JPEN J Parenter Enteral Nutr. 2006; 30:1–5.

46. Ford EG, Hull SF, Jennings LM, Andrassy RJ. Clinical comparison of tolerance to elemental or polymeric enteral feedings in the postoperative patient. J Am Coll Nutr. 1992; 11:11–16.

47. Caliari S, Benini L, Sembenini C, Gregori B, Carnielli V, Vantini I. Medium-chain triglyceride absorption in patients with pancreatic insufficiency. Scand J Gastroenterol. 1996; 31:90–94.